Literature DB >> 21633989

A matching method for improving covariate balance in cost-effectiveness analyses.

Jasjeet Singh Sekhon1, Richard D Grieve.   

Abstract

In cost-effectiveness analyses (CEA) that use randomized controlled trials (RCTs), covariates of prognostic importance may be imbalanced and warrant adjustment. In CEA that use non-randomized studies (NRS), the selection on observables assumption must hold for regression and matching methods to be unbiased. Even in restricted circumstances when this assumption is plausible, a key concern is how to adjust for imbalances in observed confounders. If the propensity score is misspecified, the covariates in the matched sample will be imbalanced, which can lead to conditional bias. To address covariate imbalance in CEA based on RCTs and NRS, this paper considers Genetic Matching. This matching method uses a search algorithm to directly maximize covariate balance. We compare Genetic and propensity score matching in Monte Carlo simulations and two case studies, CEA of pulmonary artery catheterization, based on an RCT and an NRS. The simulations show that Genetic Matching reduces the conditional bias and root mean squared error compared with propensity score matching. Genetic Matching achieves better covariate balance than the unadjusted analyses of the RCT data. In the NRS, Genetic Matching improves on the balance obtained from propensity score matching and gives substantively different estimates of incremental cost-effectiveness. We conclude that Genetic Matching can improve balance on measured covariates in CEA that use RCTs and NRS, but with NRS, this will be insufficient to reduce bias; the selection on observables assumption must also hold.
Copyright © 2011 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 21633989     DOI: 10.1002/hec.1748

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


  21 in total

1.  Matched Learning for Optimizing Individualized Treatment Strategies Using Electronic Health Records.

Authors:  Peng Wu; Donglin Zeng; Yuanjia Wang
Journal:  J Am Stat Assoc       Date:  2019-04-23       Impact factor: 5.033

2.  Health systems: changes in hospital efficiency and profitability.

Authors:  Vera Antonia Büchner; Vera Hinz; Jonas Schreyögg
Journal:  Health Care Manag Sci       Date:  2014-10-11

3.  Estimating the causal effects of chronic disease combinations on 30-day hospital readmissions based on observational Medicaid data.

Authors:  Sabrina Casucci; Li Lin; Sharon Hewner; Alexander Nikolaev
Journal:  J Am Med Inform Assoc       Date:  2018-06-01       Impact factor: 4.497

Review 4.  Secondary Use and Analysis of Big Data Collected for Patient Care.

Authors:  F J Martin-Sanchez; V Aguiar-Pulido; G H Lopez-Campos; N Peek; L Sacchi
Journal:  Yearb Med Inform       Date:  2017-09-11

5.  The effectiveness and unique contribution of neuropsychological tests and the δ latent phenotype in the differential diagnosis of dementia in the uniform data set.

Authors:  Samantha E John; Ashita S Gurnani; Cara Bussell; Jessica L Saurman; Jason W Griffin; Brandon E Gavett
Journal:  Neuropsychology       Date:  2016-11       Impact factor: 3.295

6.  Amiodarone and Trypanosoma cruzi parasitemia in patients with Chagas disease.

Authors:  Andre A L Carmo; Manoel O C Rocha; Jose L P Silva; Barbara M Ianni; Fabio Fernandes; Ester C Sabino; Antonio L P Ribeiro
Journal:  Int J Cardiol       Date:  2015-04-11       Impact factor: 4.164

7.  Modeling Covariate-Adjusted Survival for Economic Evaluations in Oncology.

Authors:  Istvan M Majer; Jean-Gabriel Castaigne; Stephen Palmer; Lucy DeCosta; Marco Campioni
Journal:  Pharmacoeconomics       Date:  2019-05       Impact factor: 4.981

8.  Psychosocial Risk Factors and Other Than Honorable Military Discharge: Providing Healthcare to Previously Ineligible Veterans.

Authors:  Eric B Elbogen; H Ryan Wagner; Mira Brancu; Nathan A Kimbrel; Jennifer C Naylor; Cindy M Swinkels; John A Fairbank
Journal:  Mil Med       Date:  2018-09-01       Impact factor: 1.437

9.  Large-Scale Discovery and Validation Studies Demonstrate Significant Reductions in Circulating Levels of IL8, IL-1Ra, MCP-1, and MIP-1β in Patients With Type 1 Diabetes.

Authors:  Sharad Purohit; Ashok Sharma; Diane Hopkins; Leigh Steed; Bruce Bode; Stephen W Anderson; John Chip Reed; R Dennis Steed; Tao Yang; Jin-Xiong She
Journal:  J Clin Endocrinol Metab       Date:  2015-07-09       Impact factor: 5.958

10.  Serum insulin-like growth factor binding protein 6 (IGFBP6) is increased in patients with type 1 diabetes and its complications.

Authors:  Shangsu Lu; Sharad Purohit; Ashok Sharma; Wenbo Zhi; Mingfang He; Yiqian Wang; Chao-Jun Li; Jin-Xiong She
Journal:  Int J Clin Exp Med       Date:  2012-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.